10:30am ET
Health and Healthcare
Biotech Short Interest Becomes Stock Specific
Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 2:44am ET
AMGN Coverage
Page 31
4:22pm ET
Health and Healthcare
The Plan to Drive Amgen Shares Up Over 70%
Amgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is the time for a break-up or other efforts. At least that is the…
Jon C. Ogg 8:40am ET
Health and Healthcare
UBS Very Positive on Top Biotech Stocks Ahead of Earnings
Rising trends in prescriptions and higher, yet beatable increases in earnings have set the table for what the UBS biotech analysts feels could be a very solid third-quarter earnings season.
10:10am ET
Health and Healthcare
Short Interest in Biotech Becomes Company Specific
The short interest data are out for the end of September settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
8:30am ET
Health and Healthcare
3 Likely Biotech Buyout Candidates
A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could be of the blockbuster variety.
10:50am ET
Health and Healthcare
Short Sellers Make Moves in Key Biotech Stocks
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the most recent report.
6:12am ET
Special Report
10 Companies Cutting the Most Jobs
Through August, planned job cuts were slightly lower than they were during the first eight months of 2013. In all, companies have announced just under 333,000 planned layoffs so far this year,…
9:20am ET
Health and Healthcare
Short Sellers Remain Vigilant Against Biotechs
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest report.
8:30am ET
Health and Healthcare
Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015
A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy for the rest of this year and 2015, and the analysts keep…
10:25am ET
Health and Healthcare
Rising Short Interest in Biotech Stocks
Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts.
9:00am ET
Investing
RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now
ThinkstockMost firms we cover on Wall Street have quantitative strategies for their clients, and often they use similar formulas to arrive at what belongs in the top quintile versus the bottom. Cash…
10:20am ET
Health and Healthcare
Do Layoffs in Biotech Send the Right Message?
This week's layoff announcement by Amgen may have investors and the public starting to rethink what "being a biotech company" really means.
Jon C. Ogg 8:55am ET
Investing
5 Huge Biotech Catalysts Right Around the Corner for Top Stocks
ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are trial data, FDA decisions and company presentations coming soon. The analysts screened…
8:25am ET
Health and Healthcare
Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks
New research reports from the biotech, health care and medical device teams at Deutsche Bank raise price targets on three top names to buy and include updates on two others.
10:15am ET
Health and Healthcare
4 Top Biotechs Expected to Beat Earnings Expectations
In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.